Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CTLA4 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement CTLA4 dans IF et BR. Il présente une réactivité envers Souris.
N° du produit ABIN7072468

Aperçu rapide pour Recombinant CTLA4 anticorps (ABIN7072468)

Antigène

Voir toutes CTLA4 Anticorps
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 133
  • 86
  • 44
  • 14
  • 3
Souris

Hôte

  • 74
  • 74
  • 24
  • 9
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Souris

Clonalité

  • 116
  • 67
  • 3
Monoclonal

Conjugué

  • 87
  • 19
  • 13
  • 13
  • 9
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CTLA4 est non-conjugé

Application

  • 102
  • 70
  • 62
  • 38
  • 28
  • 19
  • 17
  • 13
  • 10
  • 7
  • 6
  • 6
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Immunofluorescence (IF), Blocking Reagent (BR)

Clone

9D9
  • Fonction

    Anti-CTLA-4 [9D9], Mouse IgG2b, kappa

    Specificité

    The antibody is specific for CTLA-4.

    Attributs du produit

    Original Species of Ab: Mouse

    Original Format of Ab: IgG2b

    Purification

    Protein A affinity purified

    Immunogène

    The antibody was raised against CTLA-4.

    Isotype

    IgG2b kappa
  • Indications d'application

    The antibody has been used to block CTLA-4 and has been shown to enhance T-cell immunity against tumours (Quezada et al, 2006). 9D9 also has an anti-B16/BL6 melanoma effect in non-irradiated tumour-bearing recipients when given as combinatorial therapy with Gvax (Peggs et al, 2009). Selby et al. (PMID: 24777248) show how conversion of the original mouse IgG2b to a mouse IgG2a greatly increases anti-tumor activity of the 9D9 antibody in both MC38 (C57BL/6 mice) and CT26 (BALB/c mice) models. This mechanism both involves blockade of CTLA4 as well as depletion of tumor-infiltrating regulatory T-cells. Fc Silent antibodies were shown to have reduced anti-tumor activity as they did not deplete tumor infiltrating regulatory T-cells, however they lead to expansion of peripheral Tregs.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Autre désignation

    CTLA-4

    Sujet

    CD152, CTLA4, Cytotoxic T-Lymphocyte Associated Protein 4, Insulin-Dependent Diabetes Mellitus 12, Celiac Disease 3, Ligand And Transmembrane Spliced Cytotoxic T Lymphocyte Associated Antigen 4, Cytotoxic T Lymphocyte Associated Antigen 4 Short Spliced Fo

    UniProt

    P09793

    Pathways

    Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!